These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2939040)

  • 21. Inhibition of animal models of autoimmune disease and the induction of non-specific suppressor cells by SK&F 105685 and related azaspiranes.
    Badger AM; Dimartino MJ; Talmadge JE; Picker DH; Schwartz DA; Dorman JW; Mirabelli CK; Hanna N
    Int J Immunopharmacol; 1989; 11(7):839-46. PubMed ID: 2532178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of diabetes and induction of non-specific suppressor cell activity in the BB rat by an immunomodulatory azaspirane, SK&F 106610.
    Rabinovitch A; Suarez WL; Qin HY; Power RF; Badger AM
    J Autoimmun; 1993 Feb; 6(1):39-49. PubMed ID: 8457285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of suppressor cell activity in vivo and suppression of lymphoproliferative responses in vitro by SK&F 105.685 in the dog.
    Thiem PA; Kaplan JM; Bugelski PJ; Ruggieri EV; Badger AM
    Immunopharmacology; 1992; 23(2):67-74. PubMed ID: 1534791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of SK&F 105685, a novel anti-arthritic agent, on immune function in the dog.
    Kaplan JM; Badger AM; Ruggieri EV; Swift BA; Bugelski PJ
    Int J Immunopharmacol; 1993 Feb; 15(2):113-23. PubMed ID: 8468115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SK&F 105685 treatment induces suppressor cell activity and modulates cell adhesion properties in rat recipients of cardiac allografts.
    Schmidbauer G; Hancock WW; Badger AM; Kupiec-Weglinski JW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):758-60. PubMed ID: 8094912
    [No Abstract]   [Full Text] [Related]  

  • 26. Induction of non-specific suppressor cells and myeloregulatory effects of an immunomodulatory azaspirane, SK&F 105685.
    King AG; Olivera D; Talmadge JE; Badger AM
    Int J Immunopharmacol; 1991; 13(1):91-100. PubMed ID: 1827431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymphocyte electrophoresis as an indicator of modulation of concanavalin A-induced suppressor T-cells in vivo by anti-cancer drugs.
    Shimizu M; Sekine K; Kataoka T; Iwaguchi T
    Int J Immunopharmacol; 1990; 12(5):545-51. PubMed ID: 2145240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Splenic suppressor cells in adjuvant arthritic rats: effect of D-penicillamine.
    Binderup L; Bramm E; Arrigoni-Martelli E
    Agents Actions Suppl; 1980; 7():199-203. PubMed ID: 6454335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trypanosoma cruzi: inhibition by spirogermanium hydrochloride.
    Tanowitz HB; Brennessel DJ; Baum SG; Salgo MP; Braunstein V; Wittner M
    Exp Parasitol; 1987 Aug; 64(1):57-63. PubMed ID: 3301388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase I study of spirogermanium given daily.
    Legha SS; Ajani JA; Bodey GP
    J Clin Oncol; 1983 May; 1(5):331-6. PubMed ID: 6668504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T suppressor lymphocytes regulation of adjuvant arthritis in two inbred strains of rats.
    Piatier-Tonneau D; Mach PS; Kahan A; Delbarre F
    Clin Exp Immunol; 1982 Sep; 49(3):645-51. PubMed ID: 6216994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antigen-specific suppressor cells induced by FK506 in experimental autoimmune uveoretinitis in the rat.
    Kawashima H; Fujino Y; Mochizuki M
    Invest Ophthalmol Vis Sci; 1990 Dec; 31(12):2500-7. PubMed ID: 1702408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumour-induced suppressor macrophages in rats: differences in their suppressive effects on the Con A and PHA responses.
    Mizushima Y; Wepsic HT; Yamamura Y; Desilva MA
    Clin Exp Immunol; 1984 Aug; 57(2):371-9. PubMed ID: 6235988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergism between T and non-T cells in the in vivo induction and in vitro expression of graft-vs.-host disease-induced natural suppressor cells.
    Maier T; Holda JH; Claman HN
    J Exp Med; 1985 Sep; 162(3):979-92. PubMed ID: 3161977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suppression of lymphocyte proliferative responses: characterization of the suppressor and kinetics of suppression.
    Stout RD; Fisher M
    J Immunol; 1983 Apr; 130(4):1573-9. PubMed ID: 6220059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ontogeny of T-cell mitogen response in Lewis rats: II. Early appearance and loss of suppressor activity.
    Middleton PA; Bullock WW
    Dev Comp Immunol; 1984; 8(4):907-19. PubMed ID: 6240420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of spirogermanium on V79 Chinese hamster cells.
    Yang SJ; Rafla S
    Am J Clin Oncol; 1983 Jun; 6(3):331-7. PubMed ID: 6846251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional clonal deletion and suppression as complementary mechanisms operative in adult hapten-induced cytotoxic T cell tolerance.
    Good MF; Nossal GJ
    J Immunol; 1983 Dec; 131(6):2662-9. PubMed ID: 6227660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The differential effect of 2-deoxyguanosine on concanavalin A-induced suppressor and cytotoxic activity.
    Varey AM; Lelchuk R; Hutchings P; Cooke A
    Cell Immunol; 1983 Oct; 81(1):99-104. PubMed ID: 6225531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of microsomal metabolites of spirogermanium.
    Benfenati E; Zucchetti M; D'Incalci M
    Anticancer Res; 1989; 9(2):507-10. PubMed ID: 2751274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.